Institutions / Generali Investments CEE, investicni spolecnost, a.s.
Generali Investments CEE, investicni spolecnost, a.s. Source: SEC Form 13F · as of Mar 2026 Generali Investments CEE, investicni spolecnost, a.s. holds 31 biotech & pharma companies tracked by BioSniper, totaling $84.4M in value as of Mar 2026 (SEC Form 13F).
Company Shares Value LLY ELI LILLY & Co 9,233 $8.5M BIIB BIOGEN INC. 43,552 $8.0M ABBV AbbVie Inc. 36,634 $8.0M GILD GILEAD SCIENCES, INC. 53,896 $7.5M PM Philip Morris International Inc 31,424 $5.2M VRTX VERTEX PHARMACEUTICALS INC / MA 10,599 $4.7M UNH UnitedHealth Group Incorporated Common Stock (DE) 15,989 $4.3M JNJ JOHNSON & JOHNSON 17,556 $4.3M AMGN AMGEN INC 12,193 $4.3M MRK Merck & Co., Inc. 29,625 $3.6M SRPT Sarepta Therapeutics, Inc. 163,290 $3.6M PFE PFIZER INC 107,648 $3.0M AZN ASTRAZENECA PLC 15,328 $3.0M ABT ABBOTT LABORATORIES 26,384 $2.7M NVS Novartis AG 12,000 $1.8M REGN REGENERON PHARMACEUTICALS, INC. 2,170 $1.7M CAH Cardinal Health Inc. 6,000 $1.3M DGX Quest Diagnostics Incorporated 6,000 $1.2M BMY BRISTOL MYERS SQUIBB CO 17,900 $1.1M ALNY ALNYLAM PHARMACEUTICALS, INC. 2,900 $960K IQV IQVIA Holdings Inc. 4,600 $784K ELV Elevance Health Inc. 2,600 $761K VTRS Viatris Inc 50,008 $676K MRNA Moderna, Inc. 12,700 $645K NVO Novo Nordisk A/S 17,413 $640K TEVA Teva Pharmaceutical Industries Limited 20,400 $614K ZBH Zimmer Biomet Holdings Inc. 6,100 $552K COR Cencora Inc. 1,381 $434K BNTX BioNTech SE 3,200 $284K BAX Baxter International Inc. 13,000 $218K TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) 10,000 $185K
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.
All Institutions Companies Catalyst Calendar